99 related articles for article (PubMed ID: 30954690)
1. Genetic susceptibility to cervical neoplasia.
Brown MA; Leo PJ
Papillomavirus Res; 2019 Jun; 7():132-134. PubMed ID: 30954690
[TBL] [Abstract][Full Text] [Related]
2. Genetic variation in cervical preinvasive and invasive disease: a genome-wide association study.
Bowden SJ; Bodinier B; Kalliala I; Zuber V; Vuckovic D; Doulgeraki T; Whitaker MD; Wielscher M; Cartwright R; Tsilidis KK; Bennett P; Jarvelin MR; Flanagan JM; Chadeau-Hyam M; Kyrgiou M;
Lancet Oncol; 2021 Apr; 22(4):548-557. PubMed ID: 33794208
[TBL] [Abstract][Full Text] [Related]
3. Defining the genetic susceptibility to cervical neoplasia-A genome-wide association study.
Leo PJ; Madeleine MM; Wang S; Schwartz SM; Newell F; Pettersson-Kymmer U; Hemminki K; Hallmans G; Tiews S; Steinberg W; Rader JS; Castro F; Safaeian M; Franco EL; Coutlée F; Ohlsson C; Cortes A; Marshall M; Mukhopadhyay P; Cremin K; Johnson LG; Trimble CL; Garland S; Tabrizi SN; Wentzensen N; Sitas F; Little J; Cruickshank M; Frazer IH; Hildesheim A; Brown MA
PLoS Genet; 2017 Aug; 13(8):e1006866. PubMed ID: 28806749
[TBL] [Abstract][Full Text] [Related]
4. Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States.
Hildesheim A; Schiffman M; Scott DR; Marti D; Kissner T; Sherman ME; Glass AG; Manos MM; Lorincz AT; Kurman RJ; Buckland J; Rush BB; Carrington M
Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1035-41. PubMed ID: 9829713
[TBL] [Abstract][Full Text] [Related]
5. Major histocompatibility complex class II polymorphisms and risk of cervical cancer and human papillomavirus infection in Brazilian women.
Maciag PC; Schlecht NF; Souza PS; Franco EL; Villa LL; Petzl-Erler ML
Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1183-91. PubMed ID: 11097225
[TBL] [Abstract][Full Text] [Related]
6. Genetic susceptibility to infection with human papillomavirus and development of cervical cancer in women in Brazil.
de Araujo Souza PS; Villa LL
Mutat Res; 2003 Nov; 544(2-3):375-83. PubMed ID: 14644340
[TBL] [Abstract][Full Text] [Related]
7. HLA and KIR Associations of Cervical Neoplasia.
Bao X; Hanson AL; Madeleine MM; Wang SS; Schwartz SM; Newell F; Pettersson-Kymmer U; Hemminki K; Tiews S; Steinberg W; Rader JS; Castro F; Safaeian M; Franco EL; Coutlée F; Ohlsson C; Cortes A; Marshall M; Mukhopadhyay P; Cremin K; Johnson LG; Garland SM; Tabrizi SN; Wentzensen N; Sitas F; Trimble C; Little J; Cruickshank M; Frazer IH; Hildesheim A; Brown MA; Duncan EL; Sun YP; Leo PJ
J Infect Dis; 2018 Nov; 218(12):2006-2015. PubMed ID: 30099516
[TBL] [Abstract][Full Text] [Related]
8. Association between human papillomavirus 16 E6 variants and human leukocyte antigen class I polymorphism in cervical cancer of Swedish women.
Zehbe I; Mytilineos J; Wikström I; Henriksen R; Edler L; Tommasino M
Hum Immunol; 2003 May; 64(5):538-42. PubMed ID: 12691704
[TBL] [Abstract][Full Text] [Related]
9. Human leukocyte antigen class II alleles and risk of cervical cancer in China.
Wu Y; Liu B; Lin W; Xu Y; Li L; Zhang Y; Chen S; Lin Z; Xu A
Hum Immunol; 2007 Mar; 68(3):192-200. PubMed ID: 17349874
[TBL] [Abstract][Full Text] [Related]
10. A risk evaluation model of cervical cancer based on etiology and human leukocyte antigen allele susceptibility.
Hu B; Tao N; Zeng F; Zhao M; Qiu L; Chen W; Tan Y; Wei Y; Wu X; Wu X
Int J Infect Dis; 2014 Nov; 28():8-12. PubMed ID: 25223804
[TBL] [Abstract][Full Text] [Related]
11. Host and viral genetics and risk of cervical cancer: a review.
Hildesheim A; Wang SS
Virus Res; 2002 Nov; 89(2):229-40. PubMed ID: 12445662
[TBL] [Abstract][Full Text] [Related]
12. Systematic investigation of contribution of genetic variation in the HLA-DP region to cervical cancer susceptibility.
Chen D; Gyllensten U
Carcinogenesis; 2014 Aug; 35(8):1765-9. PubMed ID: 24743517
[TBL] [Abstract][Full Text] [Related]
13. Variations in immunogenetics, human papillomavirus (HPV) infection & predisposition to cervical cancer in Indian women.
Gokhale P; Kerkar S; Tongaonkar H; Chaudhari H; Warke H; Salvi V; Mania-Pramanik J
Indian J Med Res; 2014 Nov; 140 Suppl(Suppl 1):S36-43. PubMed ID: 25673541
[TBL] [Abstract][Full Text] [Related]
14. Human leukocyte antigens I and II haplotypes associated with human papillomavirus 16-positive invasive cervical cancer in Mexican women.
Hernández-Hernández DM; Cerda-Flores RM; Juárez-Cedillo T; Granados-Arriola J; Vargas-Alarcón G; Apresa-García T; Alvarado-Cabrero I; García-Carrancá A; Salcedo-Vargas M; Mohar-Betancourt A
Int J Gynecol Cancer; 2009 Aug; 19(6):1099-106. PubMed ID: 19820376
[TBL] [Abstract][Full Text] [Related]
15. HLA-DP is the cervical cancer susceptibility loci among women infected by high-risk human papillomavirus: potential implication for triage of human papillomavirus-positive women.
Jia M; Han J; Hang D; Jiang J; Wang M; Wei B; Dai J; Zhang K; Guo L; Qi J; Ma H; Shi J; Ren J; Hu Z; Dai M; Li N
Tumour Biol; 2016 Jun; 37(6):8019-25. PubMed ID: 26711785
[TBL] [Abstract][Full Text] [Related]
16. Polymorphic amino acids at codons 9 and 37 of HLA-DQB1 alleles may confer susceptibility to cervical cancer among Chinese women.
Wu Y; Chen Y; Li L; Cao Y; Liu Z; Liu B; Du Z; Zhang Y; Chen S; Lin Z; Xu A
Int J Cancer; 2006 Jun; 118(12):3006-11. PubMed ID: 16425277
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor A and MHC class I chain related gene A (MIC-A) polymorphisms in Swedish patients with cervical cancer.
Ghaderi M; Nikitina Zake L; Wallin K; Wiklund F; Hallmans G; Lenner P; Dillner J; Sanjeevi CB
Hum Immunol; 2001 Oct; 62(10):1153-8. PubMed ID: 11600224
[TBL] [Abstract][Full Text] [Related]
18. Host genetic control of HPV 16 titer in carcinoma in situ of the cervix uteri.
Beskow AH; Gyllensten UB
Int J Cancer; 2002 Oct; 101(6):526-31. PubMed ID: 12237892
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide association study of susceptibility loci for cervical cancer.
Chen D; Juko-Pecirep I; Hammer J; Ivansson E; Enroth S; Gustavsson I; Feuk L; Magnusson PK; McKay JD; Wilander E; Gyllensten U
J Natl Cancer Inst; 2013 May; 105(9):624-33. PubMed ID: 23482656
[TBL] [Abstract][Full Text] [Related]
20. Human Leukocyte Antigen Class I and Class II Polymorphisms and Serum Cytokine Profiles in Cervical Cancer.
Bahls L; Yamakawa R; Zanão K; Alfieri D; Flauzino T; Delongui F; de Abreu A; Souza R; Gimenes F; Reiche E; Borelli S; Consolaro M
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28858203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
